Aduro Biotech Enters into Exclusive License Agreement for Proprietary Neoantigen Identification Technology
Thermo Fisher Scientific Submits Premarket Approval Application to FDA for Next-Generation Sequencing-Based Oncology Test
Aduro Biotech Announces Key Preclinical Data Published Highlighting New Approach to Treat Multiple Myeloma
Juggernaut Further Increases Oversubscribed Financing to $9,557,000 due to Tremendous Strong Demand from Institutions and Accredited Investors
CoTec Holdings Corp. To Commence Expansion Drilling Program And Secure A Salter Techology Bulk Sample At The Lac Jeannine Property
